Here, we demonstrate that pharmacologic inhibition of C5a-C5aR1 signaling even after substantial plaque accumulation improved cognitive outcomes in the aggressive Arctic mouse model of AD, decreased transcription of disease-enhancing microglial genes while retaining protective gene expression and altered astrocyte polarization. The gene discussed is C5AR1; the disease is Alzheimer disease.